Key Market Indicators
Dutch pharmaceutical production is projected to soar to €1.2 billion by 2028, a significant rise from its 2023 value of approximately €660 million. This growth translates to an average annual increase of 9.3%. Since 2014, the Netherlands has experienced a robust annual growth rate of 30.6% in its pharmaceutical supply. In 2023, the country held the ninth spot in the global ranking for pharmaceutical production. Leading the rankings, Belgium matched the Netherlands with a production value of around €660 million. Italy, Spain, and Austria secured the second, third, and fourth positions, respectively.
Latest reports
Netherlands Pharmaceuticals Market Report- Q1 2025
The Netherlands' pharmaceutical market in Q1 2025 presents a dynamic landscape marked by economic stabilization, technological advancements, and strategic regulatory changes. The easing...
Netherlands Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 has been a period of significant activity and development in the Netherlands' pharmaceutical industry. This executive summary provides...
Netherlands Pharmaceuticals Market Report - Q4 2024
The fourth quarter of 2024 marked a transformative period for the pharmaceuticals sector in the Netherlands, characterized by rapid advancements, strategic collaborations, and...
